Correct diagnosis of PMMRDIA delineated from other IDH-mutant gliomas is not only important for the prognosis and possible treatment strategy of the affected individual itself, but also for family members due to the tight association of this tumor type with germline MMR deficiency. This evidence concerns the gene IDH2 and central nervous system cancer.